Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
Superinvestors holding MXCT, Q2 2026
No superinvestor reported holding MXCT in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of MXCT each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2022
0 superinvestors holding at quarter end
- Sold out
- D1 Capital Partners
Q3 2021
1 superinvestor holding at quarter end